ARCHIVES

Funding Opportunities: NCI Schedules Meeting on RFA For Pathology Informatics

This article is from The Cancer Letter archive.

Vol. 26 No. 19 | May 12, 2000

Download PDF Visit The Full Archive

Related Articles

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

December 15, 2000

NCCS Networker Volume 1 Issue 1, March 1987

March 12, 1987

DFCI Puts The Cancer Letter On Its Intranet For Employees.

February 11, 2000

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

Includes 8-page April 2002 Business & Regulatory Report.

May 3, 2002

Clinical Trials Approved By NCI CTEP Last Month

July 29, 2011